Patents by Inventor Simon Guile

Simon Guile has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • [1,2,3]-triazolo[4,5-d] pyrimidine compounds
    Patent number: 6713483
    Abstract: The invention provides [1,2,3]-triazolo[4,5-d]pyrimidine analogue compounds of formula (I) The invention is also directed to pharmaceutical compositions containing the compounds, processes for the preparation of the compounds and methods of treatment employing the compounds.
    Type: Grant
    Filed: May 13, 2002
    Date of Patent: March 30, 2004
    Assignee: AstraZeneca AB
    Inventors: Simon Guile, Brian Springthorpe
  • Novel compounds
    Publication number: 20040029899
    Abstract: The invention provides novel substituted cyclopentane compounds, their use as medicaments, compositions containing them and processes for their preparation.
    Type: Application
    Filed: April 21, 2003
    Publication date: February 12, 2004
    Inventors: Simon Guile, Barrie Martin
  • Novel compounds
    Publication number: 20040023988
    Abstract: The invention provides novel 1,2,3-triazolo[4,5-d]pyrimidine compounds, their use as medicaments, compositions containing them and processes for their preparation.
    Type: Application
    Filed: April 24, 2003
    Publication date: February 5, 2004
    Inventors: Roger Brown, Simon Guile, Garry Pairaudeau, Brian Springthorpe
  • Novel compounds
    Publication number: 20030144305
    Abstract: The invention provides new triazolo[4,5-d]pyrimidine compounds, their use as medicaments, compositions containing them and processes for their preparation.
    Type: Application
    Filed: December 20, 2002
    Publication date: July 31, 2003
    Applicant: AstraZeneca AB
    Inventors: David Hardern, Anthony Ingall, Brian Springthorpe, Paul Willis, Simon Guile
  • Triazolo(4,5-d)pyrimidine compounds
    Patent number: 6525060
    Abstract: Triazolo[4,5-d]pyrimidine compounds, their use as medicaments, compositions containing them and processes for their preparation. The compounds of the invention have the formula (I) as follows: wherein R, X and R1 through R3 are as defined in the specification.
    Type: Grant
    Filed: March 8, 2000
    Date of Patent: February 25, 2003
    Assignee: Astrazeneca UK Limited
    Inventors: David Hardern, Anthony Ingall, Brian Springthorpe, Paul Willis, Simon Guile
  • 1,2,3-triazolo[4,5-d]pyrimidines as P2T receptor antagonists
    Patent number: 6251910
    Abstract: Compounds of formula having the following stereochemistry wherein R, R1, R2, R3 and R4 are as defined in the specification. The compounds are useful as P2T receptor antagonists.
    Type: Grant
    Filed: September 21, 1998
    Date of Patent: June 26, 2001
    Assignee: AstraZeneca UK Limited
    Inventors: Simon Guile, Anthony Ingall, Brian Springthorpe, Paul Willis